Bubble Column Bioreactors Market Segmented By Animal cell / Mammalian cell, Yeast, Microorganisms Product Type in Research and development, Process development, Bioproduction, Single Cell Proteins (SCP) Application
Industry: Healthcare
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Report Type: Ongoing
Report ID: PMRREP32729
According to the latest research by Persistence Market Research, the bubble column bioreactor market is set to witness positive growth of CAGR 9% during 2021-2031. The global bubble column bioreactors market is expected to be driven by increased research and development for the production of different biochemicals.
Bubble column bioreactors are a type of bioreactor where the gas is infused from the base of the reactor for aeration and mixing purposes. These are used instead of stirred tank bioreactors where mechanical agitation is required. The bubble column bioreactors contain no moving parts and also the intake of power is low. Hence, this is low maintenance and cost-efficient bioreactor.
According to a UN report, the geriatric population will increase from 9.3 per cent in 2020 to around 16.0 per cent in 2050. This growing population is more prone to diseases. Hence, the demand for medicines will increase and will drive the market.
The major driver demand for bubble column bioreactors is their low maintenance and cost-efficient characteristics. They are used for the production of broad-spectrum antibiotics like thienamycin. This in combination with other drugs is used for the treatment of respiratory, urinary tract and gynecologic infections.
According to WHO 334 million people suffer from asthma, which is the most common chronic disease of childhood, affecting 14% of children globally. Also, the prevalence of asthma is increasing in children. In addition, the approval of new drugs for the treatment of asthma, COPD, acute lower respiratory tract infections provide an opportunity for global players operating in the market.
The bubble column bioreactors are also used for vaccine production. The impact of COVID-19 on a global scale has been tremendous. To fight against this deadly virus, vaccines are being manufactured on a large scale. The pharmaceutical, as well as biopharmaceutical companies, are investing in developing the vaccine.
An increase in the R & D investment by these companies for developing and manufacturing effective and efficient drugs is expected to increase demand for bubble column bioreactors during the forecast period.
Some of the leading manufacturers of Bubble Column Bioreactor include
By Product Type
By Application
By End-user
By Region
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company.
To know more about delivery timeline for this report Contact Sales
